Clinical Trials Browser

Metastatic Castration Resistant Prostate Cancer × Docetaxel × Genitourinary × Clear all

NCT02975934 2025-07-25

TRITON3

Phase 3 Completed

405 enrolled 34 charts 1 FDA

Metastatic Castration Resistant Prostate Cancer

NCT03328364 2024-11-21

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Metastatic Castration Resistant Prostate Cancer